CalciMedica is trading at $0.90 (5.3% down) in after-hours sessions as investors lock in gains following a board-related rally during regular trading.
- The stock previously jumped 5.6% to $0.95 after the company announced the expansion of its board and the appointment of Evgeny Zaytsev as a new director.
- The after-hours pullback reflects continued volatility for the biotech firm, which has faced pressure this year from negative Auxora AKI trial data and Nasdaq delisting notices.